Assessment of the pharmacodynamic properties of antimalarial drugs
Philosophical Transactions B · 30.04.2026 · 381 (1949)
DOI: 10.1098/rstb.2024.0339 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions B, online erschienen am 30.04.2026. Verfasst von Nicholas John White. Beteiligte Einrichtung: Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Malaria, Falciparum. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome.
Abstract (Originalsprache)
Quantifying therapeutic responses in clinical malaria is easier than for most other infections as the intraerythrocytic parasites can be counted by microscopy or estimated using quantitative PCR. In treating the blood-stage of malaria, between 107 and 1013 parasites undergo a first-order decline in densities at a rate determined by the concentrations and potency of the antimalarial drug. A simple conceptual framework based on total intravascular parasite biomass and standard sigmoid concentration–effect relationships for parasite killing explains most, but not all, aspects of antimalarial therapeutic responses, and it has proved very useful in designing chemoprevention and treatment regimens and in understanding the selection and spread of resistance. Drugs acting on younger circulating ring-stage asexual parasites (artemisinins, cipargamin, ganaplacide) provide rapid parasite clearance, which translates into faster clinical recoveries and a life-saving benefit in severe malaria. Artemisinin-sensitive Plasmodium falciparum densities decline with a half-life (PC1/2) of usually less than 5 h. Many antimalarial drugs are eliminated slowly and provide protracted exposures, which allows full treatment to be administered in 3 days, and also provides chemosuppression of newly acquired infections for 1 month. Greater availability of drug measurement in malaria-endemic areas would facilitate the field assessment of antimalarial drugs. This article is part of the Theo Murphy meeting issue ‘Evaluating anti-infective drugs’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
ORCID-Profile: Nicholas John White
Förderung
- Wellcome
Zitieren
APA
White, N. J. (2026). Assessment of the pharmacodynamic properties of antimalarial drugs. Philosophical Transactions B, 381(1949). https://doi.org/10.1098/rstb.2024.0339
Vancouver
White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs. Philosophical Transactions B. 2026;381(1949). doi:10.1098/rstb.2024.0339
BibTeX
@article{White2026,
author = {White, Nicholas John},
title = {Assessment of the pharmacodynamic properties of antimalarial drugs},
journal = {Philosophical Transactions B},
year = {2026},
volume = {381},
number = {1949},
doi = {10.1098/rstb.2024.0339}
}
EUVIMED